Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Sweet spoT for cArdiac Rhythm monitorinG After sTrokE

NCT: NCT05717504 · WITHDRAWN

NCT IDNCT05717504
StatusWITHDRAWN
Start Date2023-11
Completion2025-02
SponsorLuciano A. Sposato (OTHER)
First posted
Last updated

Brief Summary

The goal of this clinical trial is to compare the use of long-term vs. shorter-term heart monitoring to detect atrial fibrillation after stroke. Patients will be implanted with a loop recorder and will have study follow-up at 3-, 6- an 12-months after implantation. The investigators will evaluate 24 patients, between the 3 centers, in the same way the investigators plan to evaluate a larger number of participants (\>1000) in a future study. This will allow us to learn if such a study is possible, identify potential implementation challenges, and develop strategies to overcome those difficulties.

Frequently Asked Questions

What is Sweet spoT for cArdiac Rhythm monitorinG After sTrokE?

Sweet spoT for cArdiac Rhythm monitorinG After sTrokE is a clinical trial registered under NCT05717504. Current status: WITHDRAWN.

What is the status of NCT05717504?

The current status of NCT05717504 (Sweet spoT for cArdiac Rhythm monitorinG After sTrokE) is: WITHDRAWN.

When did Sweet spoT for cArdiac Rhythm monitorinG After sTrokE start?

Sweet spoT for cArdiac Rhythm monitorinG After sTrokE started on 2023-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.